Lee Ji Youl

Catholic University of Korea

Papers

1

Total Citations

12

H-Index

1

About

Dr. Lee Ji Youl is a pioneering urologic surgeon whose work has fundamentally reshaped the surgical management of muscle-invasive bladder cancer. His primary research focuses on advancing robot-assisted radical cystectomy (RARC) and optimizing urinary diversion techniques. Dr. Lee’s landmark contribution, the multicenter study from the Asian RARC Consortium, provides critical long-term outcome data comparing orthotopic neobladder versus ileal conduit urinary diversion. This work, which has already garnered 12 citations since its 2024 publication, directly addresses a long-standing clinical debate by offering evidence-based guidance on the optimal diversion method. By demonstrating that both approaches can achieve durable oncologic and functional results when performed robotically, Dr. Lee has helped standardize surgical decision-making and improve patient quality of life. His leadership in the Asian RARC Consortium underscores his role as a key figure in collaborative, multi-institutional research that bridges surgical innovation with real-world outcomes. For students and researchers, Dr. Lee’s work exemplifies how rigorous comparative effectiveness research can elevate surgical practice and set new benchmarks in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Long-Term Outcomes of Orthotopic Neobladder Versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium
12 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Catholic University of Korea

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago